,

Xing Wei1, Ziwei Guo2, Tingting Zhang3

  • 1Department of Medical Oncology, Peking University International Hospital, Beijing, People's Republic of China.

概括

使用脂质标记物的新风险评分改善了晚期肝细胞癌 (HCC) 的预后预测. 这一分数有助于比现有方法更有效地评估患者的治疗结果和持久的临床益处.